Fundraising Fox

Muna Therapeutics

Founded 2020 · 4 known investors

munatherapeutics.com ↗

Muna Therapeutics is a biotechnology company that discovers and develops therapies aimed at slowing or stopping neurodegenerative diseases, including Alzheimer's and Parkinson's. It operates in neurology-focused drug discovery and development.

BiotechLongevity

Investors · 4

Droia VenturesLeuven · $540K
Sanofi VenturesCambridge · $5M
Sofinnova PartnersParis · $540K – $27M
V-Bio VenturesGhent · $270K – $2.2M

In the news

Muna Therapeutics Awarded $1 Million Alzheimer's Association Grant to Advance Clinical Development of Novel Oral TREM2 Agonist MNA-001 for Alzheimer'sprnewswire.com · Jan 2026Muna Therapeutics ahead of new funding round: "A conference like this is an opportunity"medwatch.com · Oct 2025Muna Therapeutics Raises $73 Million to Advance Neurodegenerative Disease Focus - BioSpacebiospace.com · Jul 2021Muna Therapeutics Launches with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseasesprnewswire.com · Jul 2021

Frequently asked questions

What does Muna Therapeutics do?
Muna Therapeutics is a biotechnology company that discovers and develops therapies aimed at slowing or stopping neurodegenerative diseases, including Alzheimer's and Parkinson's. It operates in neurology-focused drug discovery and development.
Who are Muna Therapeutics's investors?
Muna Therapeutics's investors include Droia Ventures, Sanofi Ventures, Sofinnova Partners, V-Bio Ventures.